A 2 x 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model

Background After the failure of so many drugs and therapies for acute ischemic stroke, innovative approaches are needed to develop new treatments. One promising strategy is to test combinations of agents in the pre-hospital setting prior to the administration of intravenous tissue plasminogen activa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental & translational stroke medicine 2014-10, Vol.6
Hauptverfasser: Hoda, Md Nasrul, Fagan, Susan C, Khan, Mohammad B, Vaibhav, Kumar, Chaudhary, Aizaz, Wang, Phillip, Dhandapani, Krishnan M, Waller, Jennifer L, Hess, David C
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Experimental & translational stroke medicine
container_volume 6
creator Hoda, Md Nasrul
Fagan, Susan C
Khan, Mohammad B
Vaibhav, Kumar
Chaudhary, Aizaz
Wang, Phillip
Dhandapani, Krishnan M
Waller, Jennifer L
Hess, David C
description Background After the failure of so many drugs and therapies for acute ischemic stroke, innovative approaches are needed to develop new treatments. One promising strategy is to test combinations of agents in the pre-hospital setting prior to the administration of intravenous tissue plasminogen activator (IV-tPA) and/ or the use of mechanical reperfusion devices in the hospital. Methods We performed a 2 x 2 factorial design preclinical trial where we tested minocycline (MINO), remote ischemic perconditioning (RIPerC) and their combination treatment in a thromboembolic clot model of stroke in mice, without IV-tPA or later treated with IV-tPA at 4 hours post-stroke. Cerebral blood flow (CBF) was measured by laser speckle contrast imaging (LSCI), behavioral outcomes as neurological deficit score (NDS) and adhesive tape removal test, and infarct size measurement were performed at 48 hours post-stroke. Mice within the experimental sets were randomized for the different treatments, and all outcome measures were blinded. Results RIPerC significantly improved CBF as measured by LSCI in both with and without tPA treated mice (P < 0.001). MINO and RIPerC treatment were effective alone at reducing infarct size (p < 0.0001) and improving short-term functional outcomes (p < 0.001) in the tPA and non-tPA treated animals. The combination treatment of MINO and RIPerC significantly reduced the infarct size greater than either intervention alone (p < 0.05). There were trends in favor of improving functional outcomes after combination treatment of MINO and RIPerC; however combination treatment group was not significantly different than the individual treatments of MINO and RIPerC. There was no "statistical" interaction between minocycline and RIPerC treatments indicating that the effects of RIPerC and MINO were additive and not synergistic on the outcome measures. Conclusion In the future, combining these two safe and low cost interventions in the ambulance has the potential to "freeze" the penumbra and improve outcomes in stroke patients. This pre-clinical 2 x 2 design can be easily translated into a pre-hospital clinical trial. Keywords: Thromboembolic stroke, Minocycline, Remote ischemic perconditioning, Neurovascular protection, Intravenous tPA
doi_str_mv 10.1186/2040-7378-6-10
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A541245828</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541245828</galeid><sourcerecordid>A541245828</sourcerecordid><originalsourceid>FETCH-LOGICAL-g988-efc75baace99eb0629fb9084b51d95d270210187f92c9b02a1a42720a22c062a3</originalsourceid><addsrcrecordid>eNptUE1LBDEMHUTB9ePqOSB4G22781Vvi_gFgpe9L5lOulPttEungvun_I12VGQFCSHJ470Xkiw74-yS86a6EqxgeT2vm7zKOdvLZr_A_k5_mB2N4wtjlZxXbJZ9LEDAe0qNKvpg0EJHo1k70D5A7AmUH1rjMBrvpjngZgtew2CcV1tljSNA10GgwUcCM6qeBqNgQ0F515lJZ9z6Gkhro1BtwThA2ASatAmxEL_WJnh4C5Nd7EPa6SmlTU5jDP6VYPAd2ZPsQKMd6fSnHmfLu9vlzUP-9Hz_eLN4yteyaXLSqi5bREVSUssqIXUrWVO0Je9k2YmaCc54U2splGyZQI6FqAVDIVRi4_w4O_-2XaOllXHax4BqSMetFmXBRVE2okmsy39YKbrpA96RNgn_I7jYEfSENvajt2_Tj8Zd4id6nY8W</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A 2 x 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Hoda, Md Nasrul ; Fagan, Susan C ; Khan, Mohammad B ; Vaibhav, Kumar ; Chaudhary, Aizaz ; Wang, Phillip ; Dhandapani, Krishnan M ; Waller, Jennifer L ; Hess, David C</creator><creatorcontrib>Hoda, Md Nasrul ; Fagan, Susan C ; Khan, Mohammad B ; Vaibhav, Kumar ; Chaudhary, Aizaz ; Wang, Phillip ; Dhandapani, Krishnan M ; Waller, Jennifer L ; Hess, David C</creatorcontrib><description>Background After the failure of so many drugs and therapies for acute ischemic stroke, innovative approaches are needed to develop new treatments. One promising strategy is to test combinations of agents in the pre-hospital setting prior to the administration of intravenous tissue plasminogen activator (IV-tPA) and/ or the use of mechanical reperfusion devices in the hospital. Methods We performed a 2 x 2 factorial design preclinical trial where we tested minocycline (MINO), remote ischemic perconditioning (RIPerC) and their combination treatment in a thromboembolic clot model of stroke in mice, without IV-tPA or later treated with IV-tPA at 4 hours post-stroke. Cerebral blood flow (CBF) was measured by laser speckle contrast imaging (LSCI), behavioral outcomes as neurological deficit score (NDS) and adhesive tape removal test, and infarct size measurement were performed at 48 hours post-stroke. Mice within the experimental sets were randomized for the different treatments, and all outcome measures were blinded. Results RIPerC significantly improved CBF as measured by LSCI in both with and without tPA treated mice (P &lt; 0.001). MINO and RIPerC treatment were effective alone at reducing infarct size (p &lt; 0.0001) and improving short-term functional outcomes (p &lt; 0.001) in the tPA and non-tPA treated animals. The combination treatment of MINO and RIPerC significantly reduced the infarct size greater than either intervention alone (p &lt; 0.05). There were trends in favor of improving functional outcomes after combination treatment of MINO and RIPerC; however combination treatment group was not significantly different than the individual treatments of MINO and RIPerC. There was no "statistical" interaction between minocycline and RIPerC treatments indicating that the effects of RIPerC and MINO were additive and not synergistic on the outcome measures. Conclusion In the future, combining these two safe and low cost interventions in the ambulance has the potential to "freeze" the penumbra and improve outcomes in stroke patients. This pre-clinical 2 x 2 design can be easily translated into a pre-hospital clinical trial. Keywords: Thromboembolic stroke, Minocycline, Remote ischemic perconditioning, Neurovascular protection, Intravenous tPA</description><identifier>ISSN: 2040-7378</identifier><identifier>EISSN: 2040-7378</identifier><identifier>DOI: 10.1186/2040-7378-6-10</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><ispartof>Experimental &amp; translational stroke medicine, 2014-10, Vol.6</ispartof><rights>COPYRIGHT 2014 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Hoda, Md Nasrul</creatorcontrib><creatorcontrib>Fagan, Susan C</creatorcontrib><creatorcontrib>Khan, Mohammad B</creatorcontrib><creatorcontrib>Vaibhav, Kumar</creatorcontrib><creatorcontrib>Chaudhary, Aizaz</creatorcontrib><creatorcontrib>Wang, Phillip</creatorcontrib><creatorcontrib>Dhandapani, Krishnan M</creatorcontrib><creatorcontrib>Waller, Jennifer L</creatorcontrib><creatorcontrib>Hess, David C</creatorcontrib><title>A 2 x 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model</title><title>Experimental &amp; translational stroke medicine</title><description>Background After the failure of so many drugs and therapies for acute ischemic stroke, innovative approaches are needed to develop new treatments. One promising strategy is to test combinations of agents in the pre-hospital setting prior to the administration of intravenous tissue plasminogen activator (IV-tPA) and/ or the use of mechanical reperfusion devices in the hospital. Methods We performed a 2 x 2 factorial design preclinical trial where we tested minocycline (MINO), remote ischemic perconditioning (RIPerC) and their combination treatment in a thromboembolic clot model of stroke in mice, without IV-tPA or later treated with IV-tPA at 4 hours post-stroke. Cerebral blood flow (CBF) was measured by laser speckle contrast imaging (LSCI), behavioral outcomes as neurological deficit score (NDS) and adhesive tape removal test, and infarct size measurement were performed at 48 hours post-stroke. Mice within the experimental sets were randomized for the different treatments, and all outcome measures were blinded. Results RIPerC significantly improved CBF as measured by LSCI in both with and without tPA treated mice (P &lt; 0.001). MINO and RIPerC treatment were effective alone at reducing infarct size (p &lt; 0.0001) and improving short-term functional outcomes (p &lt; 0.001) in the tPA and non-tPA treated animals. The combination treatment of MINO and RIPerC significantly reduced the infarct size greater than either intervention alone (p &lt; 0.05). There were trends in favor of improving functional outcomes after combination treatment of MINO and RIPerC; however combination treatment group was not significantly different than the individual treatments of MINO and RIPerC. There was no "statistical" interaction between minocycline and RIPerC treatments indicating that the effects of RIPerC and MINO were additive and not synergistic on the outcome measures. Conclusion In the future, combining these two safe and low cost interventions in the ambulance has the potential to "freeze" the penumbra and improve outcomes in stroke patients. This pre-clinical 2 x 2 design can be easily translated into a pre-hospital clinical trial. Keywords: Thromboembolic stroke, Minocycline, Remote ischemic perconditioning, Neurovascular protection, Intravenous tPA</description><issn>2040-7378</issn><issn>2040-7378</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptUE1LBDEMHUTB9ePqOSB4G22781Vvi_gFgpe9L5lOulPttEungvun_I12VGQFCSHJ470Xkiw74-yS86a6EqxgeT2vm7zKOdvLZr_A_k5_mB2N4wtjlZxXbJZ9LEDAe0qNKvpg0EJHo1k70D5A7AmUH1rjMBrvpjngZgtew2CcV1tljSNA10GgwUcCM6qeBqNgQ0F515lJZ9z6Gkhro1BtwThA2ASatAmxEL_WJnh4C5Nd7EPa6SmlTU5jDP6VYPAd2ZPsQKMd6fSnHmfLu9vlzUP-9Hz_eLN4yteyaXLSqi5bREVSUssqIXUrWVO0Je9k2YmaCc54U2splGyZQI6FqAVDIVRi4_w4O_-2XaOllXHax4BqSMetFmXBRVE2okmsy39YKbrpA96RNgn_I7jYEfSENvajt2_Tj8Zd4id6nY8W</recordid><startdate>20141009</startdate><enddate>20141009</enddate><creator>Hoda, Md Nasrul</creator><creator>Fagan, Susan C</creator><creator>Khan, Mohammad B</creator><creator>Vaibhav, Kumar</creator><creator>Chaudhary, Aizaz</creator><creator>Wang, Phillip</creator><creator>Dhandapani, Krishnan M</creator><creator>Waller, Jennifer L</creator><creator>Hess, David C</creator><general>BioMed Central Ltd</general><scope/></search><sort><creationdate>20141009</creationdate><title>A 2 x 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model</title><author>Hoda, Md Nasrul ; Fagan, Susan C ; Khan, Mohammad B ; Vaibhav, Kumar ; Chaudhary, Aizaz ; Wang, Phillip ; Dhandapani, Krishnan M ; Waller, Jennifer L ; Hess, David C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g988-efc75baace99eb0629fb9084b51d95d270210187f92c9b02a1a42720a22c062a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoda, Md Nasrul</creatorcontrib><creatorcontrib>Fagan, Susan C</creatorcontrib><creatorcontrib>Khan, Mohammad B</creatorcontrib><creatorcontrib>Vaibhav, Kumar</creatorcontrib><creatorcontrib>Chaudhary, Aizaz</creatorcontrib><creatorcontrib>Wang, Phillip</creatorcontrib><creatorcontrib>Dhandapani, Krishnan M</creatorcontrib><creatorcontrib>Waller, Jennifer L</creatorcontrib><creatorcontrib>Hess, David C</creatorcontrib><jtitle>Experimental &amp; translational stroke medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoda, Md Nasrul</au><au>Fagan, Susan C</au><au>Khan, Mohammad B</au><au>Vaibhav, Kumar</au><au>Chaudhary, Aizaz</au><au>Wang, Phillip</au><au>Dhandapani, Krishnan M</au><au>Waller, Jennifer L</au><au>Hess, David C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A 2 x 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model</atitle><jtitle>Experimental &amp; translational stroke medicine</jtitle><date>2014-10-09</date><risdate>2014</risdate><volume>6</volume><issn>2040-7378</issn><eissn>2040-7378</eissn><abstract>Background After the failure of so many drugs and therapies for acute ischemic stroke, innovative approaches are needed to develop new treatments. One promising strategy is to test combinations of agents in the pre-hospital setting prior to the administration of intravenous tissue plasminogen activator (IV-tPA) and/ or the use of mechanical reperfusion devices in the hospital. Methods We performed a 2 x 2 factorial design preclinical trial where we tested minocycline (MINO), remote ischemic perconditioning (RIPerC) and their combination treatment in a thromboembolic clot model of stroke in mice, without IV-tPA or later treated with IV-tPA at 4 hours post-stroke. Cerebral blood flow (CBF) was measured by laser speckle contrast imaging (LSCI), behavioral outcomes as neurological deficit score (NDS) and adhesive tape removal test, and infarct size measurement were performed at 48 hours post-stroke. Mice within the experimental sets were randomized for the different treatments, and all outcome measures were blinded. Results RIPerC significantly improved CBF as measured by LSCI in both with and without tPA treated mice (P &lt; 0.001). MINO and RIPerC treatment were effective alone at reducing infarct size (p &lt; 0.0001) and improving short-term functional outcomes (p &lt; 0.001) in the tPA and non-tPA treated animals. The combination treatment of MINO and RIPerC significantly reduced the infarct size greater than either intervention alone (p &lt; 0.05). There were trends in favor of improving functional outcomes after combination treatment of MINO and RIPerC; however combination treatment group was not significantly different than the individual treatments of MINO and RIPerC. There was no "statistical" interaction between minocycline and RIPerC treatments indicating that the effects of RIPerC and MINO were additive and not synergistic on the outcome measures. Conclusion In the future, combining these two safe and low cost interventions in the ambulance has the potential to "freeze" the penumbra and improve outcomes in stroke patients. This pre-clinical 2 x 2 design can be easily translated into a pre-hospital clinical trial. Keywords: Thromboembolic stroke, Minocycline, Remote ischemic perconditioning, Neurovascular protection, Intravenous tPA</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/2040-7378-6-10</doi></addata></record>
fulltext fulltext
identifier ISSN: 2040-7378
ispartof Experimental & translational stroke medicine, 2014-10, Vol.6
issn 2040-7378
2040-7378
language eng
recordid cdi_gale_infotracmisc_A541245828
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central; Alma/SFX Local Collection
title A 2 x 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A53%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%202%20x%202%20factorial%20design%20for%20the%20combination%20therapy%20of%20minocycline%20and%20remote%20ischemic%20perconditioning:%20efficacy%20in%20a%20preclinical%20trial%20in%20murine%20thromboembolic%20stroke%20model&rft.jtitle=Experimental%20&%20translational%20stroke%20medicine&rft.au=Hoda,%20Md%20Nasrul&rft.date=2014-10-09&rft.volume=6&rft.issn=2040-7378&rft.eissn=2040-7378&rft_id=info:doi/10.1186/2040-7378-6-10&rft_dat=%3Cgale%3EA541245828%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A541245828&rfr_iscdi=true